SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-075719
Filing Date
2024-06-27
Accepted
2024-06-27 16:54:23
Documents
1
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2418415-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2418415-2_4seq1.xml 4 4149
  Complete submission text file 0001104659-24-075719.txt   5852
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Morrison Briggs (Reporting) CIK: 0001654430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 241080007